Industry Research Reports

Home > Reports > Service & Software > Global Proteomics Research Services Market Research Report 2026

Global Proteomics Research Services Market Research Report 2026

Industry: Service & Software

Published Date: 2026-07-16

Pages: 186 Pages

Report ld: 6976891

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Proteomics Research Services Market Size(US$)

CAGR 2026-2032

10.4%

Market Size,2032

USD 6,602

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 3,652 million

Market Forecast in 2032(Value)

US$ 6,602 million

CAGR

10.4%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Proteomics Research Services market was valued at US$ 3392 million in 2025 and is anticipated to reach US$ 6602 million by 2032, at a CAGR of 10.4% from 2026 to 2032.

Proteomics Research Services refer to professional outsourced research solutions that utilize advanced proteomics technologies to provide protein identification, quantification, functional characterization, data interpretation, and biological mechanism discovery services for academic institutions, pharmaceutical companies, biotechnology companies, healthcare organizations, and research users.

These services typically include sample preparation, protein extraction, enzymatic digestion, liquid chromatography separation, high-resolution mass spectrometry analysis (LC-MS/MS), multiplex protein profiling, post-translational modification (PTM) analysis, protein interaction studies, single-cell proteomics, spatial proteomics, and bioinformatics interpretation.

Unlike traditional laboratory outsourcing, proteomics research services integrate high-sensitivity analytical platforms, standardized workflows, large-scale protein databases, and advanced computational analysis capabilities to transform complex protein datasets into actionable biological insights. The service model has become a critical infrastructure for drug discovery, disease mechanism investigation, biomarker identification, precision medicine, immunotherapy development, and translational research. Driven by artificial intelligence, multi-omics integration, and high-throughput technologies, proteomics research services are evolving from simple analytical outsourcing toward integrated solutions combining experimental design, technology platforms, data analytics, and scientific discovery.

The proteomics research services industry primarily adopts a technology-driven CRO (Contract Research Organization) business model. Service providers establish advanced mass spectrometry platforms, multiplex protein analysis systems, automated sample preparation capabilities, and bioinformatics infrastructure to deliver customized research solutions. Typical workflows include project consultation, experimental design, sample quality control, analytical testing, data processing, statistical interpretation, biological validation, and final research reporting.

From an industry chain perspective, upstream suppliers include mass spectrometry manufacturers, liquid chromatography providers, laboratory consumable suppliers, biochemical reagent companies, antibody developers, protein standards suppliers, and computing infrastructure providers. The midstream sector consists of specialized proteomics CRO companies, multi-omics service platforms, and research technology providers. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, universities, government research organizations, and agricultural biotechnology companies. Large-scale CRO providers leverage global laboratory networks and standardized quality systems to support pharmaceutical customers from early discovery through translational research.

Proteomics research services generally achieve attractive profitability due to their high technical complexity and specialized capabilities. Advanced services such as clinical proteomics, drug target discovery, spatial proteomics, and single-cell proteomics typically generate gross margins of approximately 50%-70% due to high technical barriers, significant equipment investment, and specialized expertise requirements. Standardized protein analysis and routine mass spectrometry services usually achieve margins of around 30%-50% because of stronger competition. Companies with proprietary algorithms, biological databases, and differentiated analytical platforms can achieve margins above 60% through technology advantages and long-term customer relationships.

Proteomics research services are becoming a strategic growth area within the global life science research ecosystem. Increasing investment in innovative drug development is accelerating demand for efficient and accurate target discovery, biomarker identification, and mechanism-of-action studies. Proteomics provides functional molecular information that cannot be fully captured by genomics alone, creating significant value in oncology, immunology, neurological research, metabolic disease studies, and precision medicine. The integration of multi-omics technologies, artificial intelligence-driven data interpretation, and automated laboratory platforms will further improve research efficiency and commercial scalability.

The proteomics research services industry faces challenges including high technological complexity, significant capital requirements, limited analytical standardization, and shortages of specialized scientific talent. Advanced mass spectrometry platforms and emerging protein analysis technologies require continuous investment in research infrastructure. In addition, demand fluctuations caused by biotechnology funding cycles, drug development timelines, and customer budget adjustments may create operational uncertainty. Companies must continuously strengthen technology platforms, quality systems, and computational capabilities to maintain competitive advantages.

Future demand for proteomics research services will increasingly move toward high-throughput analysis, precision applications, clinical translation, and AI-enabled interpretation. Pharmaceutical and biotechnology companies will remain major customers by outsourcing proteomics studies to reduce R&D costs and accelerate drug development timelines. Hospitals and diagnostic companies will expand applications in early disease detection, biomarker validation, and companion diagnostics. Academic and research institutions will continue advancing single-cell proteomics, spatial proteomics, and multi-omics integration. As life science research becomes increasingly data-driven, proteomics service providers with advanced technology platforms, analytical capabilities, and global delivery networks will capture stronger market opportunities.

This report delivers a comprehensive overview of the global Proteomics Research Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Proteomics Research Services. The Proteomics Research Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Proteomics Research Services market comprehensively. Regional market sizes by Type, by Application, by End User, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Proteomics Research Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
CellCarta
PTM BIO
Standard Biotools
Labcorp
BostonGene
APTBIO
Cell Signaling Technology (CST)
Inotiv
Bruker Spatial Biology
BGI Genomics
Biognosys
Crown Bioscience
Eurofins Scientific
Charles River Laboratories
Discovery Life Sciences
Shanghai OE Biotech
Biodesix
Novogene
OmicScouts (Momentum Biotechnologies)
Lc-Bio Technologies
Creative Proteomics
Metware Biotechnology
GENEWIZ (Azenta Life Sciences)
CDI Labs
Evotec
MS Bioworks
Shanghai Bioprofile
MtoZ-Biolabs
Shanghai Majorbio Bio-Pharm
Firalis Molecular Precision
CD Genomics
MRM Proteomics
Panome Bio
Beijing Biomarker Technologies
Sampled (Infinity Biologix)
Sinotech Genomics
Applied Biomics
Westlake Omics
Sapient Bioanalytics
RxCelerate
Vizgen
Allumiqs
VProteomics
Precision Biomarker Laboratories (PBL)
Proteome Sciences
Proteomics International
TATAA Biocenter
Cosmos Wisdom

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Standard Proteomics
Modified Proteomics
Spatial Proteomics
Blood Proteomics
Other Proteomics

Segment by Application

Clinical Diagnostics
Drug Discovery
Others

Segment by Category

Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others

Segment by Division

Oncology
Cardiovascular
Agriculture
Neuroscience
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by End User, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Proteomics Research Services companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Proteomics Research Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Standard Proteomics

1.2.3 Modified Proteomics

1.2.4 Spatial Proteomics

1.2.5 Blood Proteomics

1.2.6 Other Proteomics

1.3 Market by End User

1.3.1 Global Proteomics Research Services Market Size Growth Rate by End User: 2021 vs 2025 vs 2032

1.3.2 Universities and Research Institutes

1.3.3 Hospitals

1.3.4 Pharmaceutical Companies

1.3.5 Others

1.4 Market by Research Areas

1.4.1 Global Proteomics Research Services Market Size Growth Rate by Research Areas: 2021 vs 2025 vs 2032

1.4.2 Oncology

1.4.3 Cardiovascular

1.4.4 Agriculture

1.4.5 Neuroscience

1.4.6 Other

1.5 Market by Application

1.5.1 Global Proteomics Research Services Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Clinical Diagnostics

1.5.3 Drug Discovery

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Proteomics Research Services Market Perspective (2021–2032)

2.2 Global Proteomics Research Services Growth Trends by Region

2.2.1 Global Proteomics Research Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Proteomics Research Services Historic Market Size by Region (2021–2026)

2.2.3 Proteomics Research Services Forecasted Market Size by Region (2027–2032)

2.3 Proteomics Research Services Market Dynamics

2.3.1 Proteomics Research Services Industry Trends

2.3.2 Proteomics Research Services Market Drivers

2.3.3 Proteomics Research Services Market Challenges

2.3.4 Proteomics Research Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Proteomics Research Services Players by Revenue

3.1.1 Global Top Proteomics Research Services Players by Revenue (2021–2026)

3.1.2 Global Proteomics Research Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Proteomics Research Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Proteomics Research Services Revenue

3.4 Global Proteomics Research Services Market Concentration Ratio

3.4.1 Global Proteomics Research Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Proteomics Research Services Revenue in 2025

3.5 Global Key Players of Proteomics Research Services Head Offices and Areas Served

3.6 Global Key Players of Proteomics Research Services, Products and Applications

3.7 Global Key Players of Proteomics Research Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Proteomics Research Services Breakdown Data by Type

4.1 Global Proteomics Research Services Historic Market Size by Type (2021–2026)

4.2 Global Proteomics Research Services Forecasted Market Size by Type (2027–2032)

5 Proteomics Research Services Breakdown Data by Application

5.1 Global Proteomics Research Services Historic Market Size by Application (2021–2026)

5.2 Global Proteomics Research Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Proteomics Research Services Market Size (2021–2032)

6.2 North America Proteomics Research Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Proteomics Research Services Market Size by Country (2021–2026)

6.4 North America Proteomics Research Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Proteomics Research Services Market Size (2021–2032)

7.2 Europe Proteomics Research Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Proteomics Research Services Market Size by Country (2021–2026)

7.4 Europe Proteomics Research Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Proteomics Research Services Market Size (2021–2032)

8.2 Asia-Pacific Proteomics Research Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Proteomics Research Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Proteomics Research Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Proteomics Research Services Market Size (2021–2032)

9.2 Latin America Proteomics Research Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Proteomics Research Services Market Size by Country (2021–2026)

9.4 Latin America Proteomics Research Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Proteomics Research Services Market Size (2021–2032)

10.2 Middle East & Africa Proteomics Research Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Proteomics Research Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Proteomics Research Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Olink (Thermo Fisher Scientific)

11.1.1 Olink (Thermo Fisher Scientific) Company Details

11.1.2 Olink (Thermo Fisher Scientific) Business Overview

11.1.3 Olink (Thermo Fisher Scientific) Proteomics Research Services Introduction

11.1.4 Olink (Thermo Fisher Scientific) Revenue in Proteomics Research Services Business (2021–2026)

11.1.5 Olink (Thermo Fisher Scientific) Recent Development

11.2 SomaLogic (Illumina)

11.2.1 SomaLogic (Illumina) Company Details

11.2.2 SomaLogic (Illumina) Business Overview

11.2.3 SomaLogic (Illumina) Proteomics Research Services Introduction

11.2.4 SomaLogic (Illumina) Revenue in Proteomics Research Services Business (2021–2026)

11.2.5 SomaLogic (Illumina) Recent Development

11.3 CellCarta

11.3.1 CellCarta Company Details

11.3.2 CellCarta Business Overview

11.3.3 CellCarta Proteomics Research Services Introduction

11.3.4 CellCarta Revenue in Proteomics Research Services Business (2021–2026)

11.3.5 CellCarta Recent Development

11.4 PTM BIO

11.4.1 PTM BIO Company Details

11.4.2 PTM BIO Business Overview

11.4.3 PTM BIO Proteomics Research Services Introduction

11.4.4 PTM BIO Revenue in Proteomics Research Services Business (2021–2026)

11.4.5 PTM BIO Recent Development

11.5 Standard Biotools

11.5.1 Standard Biotools Company Details

11.5.2 Standard Biotools Business Overview

11.5.3 Standard Biotools Proteomics Research Services Introduction

11.5.4 Standard Biotools Revenue in Proteomics Research Services Business (2021–2026)

11.5.5 Standard Biotools Recent Development

11.6 Labcorp

11.6.1 Labcorp Company Details

11.6.2 Labcorp Business Overview

11.6.3 Labcorp Proteomics Research Services Introduction

11.6.4 Labcorp Revenue in Proteomics Research Services Business (2021–2026)

11.6.5 Labcorp Recent Development

11.7 BostonGene

11.7.1 BostonGene Company Details

11.7.2 BostonGene Business Overview

11.7.3 BostonGene Proteomics Research Services Introduction

11.7.4 BostonGene Revenue in Proteomics Research Services Business (2021–2026)

11.7.5 BostonGene Recent Development

11.8 APTBIO

11.8.1 APTBIO Company Details

11.8.2 APTBIO Business Overview

11.8.3 APTBIO Proteomics Research Services Introduction

11.8.4 APTBIO Revenue in Proteomics Research Services Business (2021–2026)

11.8.5 APTBIO Recent Development

11.9 Cell Signaling Technology (CST)

11.9.1 Cell Signaling Technology (CST) Company Details

11.9.2 Cell Signaling Technology (CST) Business Overview

11.9.3 Cell Signaling Technology (CST) Proteomics Research Services Introduction

11.9.4 Cell Signaling Technology (CST) Revenue in Proteomics Research Services Business (2021–2026)

11.9.5 Cell Signaling Technology (CST) Recent Development

11.10 Inotiv

11.10.1 Inotiv Company Details

11.10.2 Inotiv Business Overview

11.10.3 Inotiv Proteomics Research Services Introduction

11.10.4 Inotiv Revenue in Proteomics Research Services Business (2021–2026)

11.10.5 Inotiv Recent Development

11.11 Bruker Spatial Biology

11.11.1 Bruker Spatial Biology Company Details

11.11.2 Bruker Spatial Biology Business Overview

11.11.3 Bruker Spatial Biology Proteomics Research Services Introduction

11.11.4 Bruker Spatial Biology Revenue in Proteomics Research Services Business (2021–2026)

11.11.5 Bruker Spatial Biology Recent Development

11.12 BGI Genomics

11.12.1 BGI Genomics Company Details

11.12.2 BGI Genomics Business Overview

11.12.3 BGI Genomics Proteomics Research Services Introduction

11.12.4 BGI Genomics Revenue in Proteomics Research Services Business (2021–2026)

11.12.5 BGI Genomics Recent Development

11.13 Biognosys

11.13.1 Biognosys Company Details

11.13.2 Biognosys Business Overview

11.13.3 Biognosys Proteomics Research Services Introduction

11.13.4 Biognosys Revenue in Proteomics Research Services Business (2021–2026)

11.13.5 Biognosys Recent Development

11.14 Crown Bioscience

11.14.1 Crown Bioscience Company Details

11.14.2 Crown Bioscience Business Overview

11.14.3 Crown Bioscience Proteomics Research Services Introduction

11.14.4 Crown Bioscience Revenue in Proteomics Research Services Business (2021–2026)

11.14.5 Crown Bioscience Recent Development

11.15 Eurofins Scientific

11.15.1 Eurofins Scientific Company Details

11.15.2 Eurofins Scientific Business Overview

11.15.3 Eurofins Scientific Proteomics Research Services Introduction

11.15.4 Eurofins Scientific Revenue in Proteomics Research Services Business (2021–2026)

11.15.5 Eurofins Scientific Recent Development

11.16 Charles River Laboratories

11.16.1 Charles River Laboratories Company Details

11.16.2 Charles River Laboratories Business Overview

11.16.3 Charles River Laboratories Proteomics Research Services Introduction

11.16.4 Charles River Laboratories Revenue in Proteomics Research Services Business (2021–2026)

11.16.5 Charles River Laboratories Recent Development

11.17 Discovery Life Sciences

11.17.1 Discovery Life Sciences Company Details

11.17.2 Discovery Life Sciences Business Overview

11.17.3 Discovery Life Sciences Proteomics Research Services Introduction

11.17.4 Discovery Life Sciences Revenue in Proteomics Research Services Business (2021–2026)

11.17.5 Discovery Life Sciences Recent Development

11.18 Shanghai OE Biotech

11.18.1 Shanghai OE Biotech Company Details

11.18.2 Shanghai OE Biotech Business Overview

11.18.3 Shanghai OE Biotech Proteomics Research Services Introduction

11.18.4 Shanghai OE Biotech Revenue in Proteomics Research Services Business (2021–2026)

11.18.5 Shanghai OE Biotech Recent Development

11.19 Biodesix

11.19.1 Biodesix Company Details

11.19.2 Biodesix Business Overview

11.19.3 Biodesix Proteomics Research Services Introduction

11.19.4 Biodesix Revenue in Proteomics Research Services Business (2021–2026)

11.19.5 Biodesix Recent Development

11.20 Novogene

11.20.1 Novogene Company Details

11.20.2 Novogene Business Overview

11.20.3 Novogene Proteomics Research Services Introduction

11.20.4 Novogene Revenue in Proteomics Research Services Business (2021–2026)

11.20.5 Novogene Recent Development

11.21 OmicScouts (Momentum Biotechnologies)

11.21.1 OmicScouts (Momentum Biotechnologies) Company Details

11.21.2 OmicScouts (Momentum Biotechnologies) Business Overview

11.21.3 OmicScouts (Momentum Biotechnologies) Proteomics Research Services Introduction

11.21.4 OmicScouts (Momentum Biotechnologies) Revenue in Proteomics Research Services Business (2021–2026)

11.21.5 OmicScouts (Momentum Biotechnologies) Recent Development

11.22 Lc-Bio Technologies

11.22.1 Lc-Bio Technologies Company Details

11.22.2 Lc-Bio Technologies Business Overview

11.22.3 Lc-Bio Technologies Proteomics Research Services Introduction

11.22.4 Lc-Bio Technologies Revenue in Proteomics Research Services Business (2021–2026)

11.22.5 Lc-Bio Technologies Recent Development

11.23 Creative Proteomics

11.23.1 Creative Proteomics Company Details

11.23.2 Creative Proteomics Business Overview

11.23.3 Creative Proteomics Proteomics Research Services Introduction

11.23.4 Creative Proteomics Revenue in Proteomics Research Services Business (2021–2026)

11.23.5 Creative Proteomics Recent Development

11.24 Metware Biotechnology

11.24.1 Metware Biotechnology Company Details

11.24.2 Metware Biotechnology Business Overview

11.24.3 Metware Biotechnology Proteomics Research Services Introduction

11.24.4 Metware Biotechnology Revenue in Proteomics Research Services Business (2021–2026)

11.24.5 Metware Biotechnology Recent Development

11.25 GENEWIZ (Azenta Life Sciences)

11.25.1 GENEWIZ (Azenta Life Sciences) Company Details

11.25.2 GENEWIZ (Azenta Life Sciences) Business Overview

11.25.3 GENEWIZ (Azenta Life Sciences) Proteomics Research Services Introduction

11.25.4 GENEWIZ (Azenta Life Sciences) Revenue in Proteomics Research Services Business (2021–2026)

11.25.5 GENEWIZ (Azenta Life Sciences) Recent Development

11.26 CDI Labs

11.26.1 CDI Labs Company Details

11.26.2 CDI Labs Business Overview

11.26.3 CDI Labs Proteomics Research Services Introduction

11.26.4 CDI Labs Revenue in Proteomics Research Services Business (2021–2026)

11.26.5 CDI Labs Recent Development

11.27 Evotec

11.27.1 Evotec Company Details

11.27.2 Evotec Business Overview

11.27.3 Evotec Proteomics Research Services Introduction

11.27.4 Evotec Revenue in Proteomics Research Services Business (2021–2026)

11.27.5 Evotec Recent Development

11.28 MS Bioworks

11.28.1 MS Bioworks Company Details

11.28.2 MS Bioworks Business Overview

11.28.3 MS Bioworks Proteomics Research Services Introduction

11.28.4 MS Bioworks Revenue in Proteomics Research Services Business (2021–2026)

11.28.5 MS Bioworks Recent Development

11.29 Shanghai Bioprofile

11.29.1 Shanghai Bioprofile Company Details

11.29.2 Shanghai Bioprofile Business Overview

11.29.3 Shanghai Bioprofile Proteomics Research Services Introduction

11.29.4 Shanghai Bioprofile Revenue in Proteomics Research Services Business (2021–2026)

11.29.5 Shanghai Bioprofile Recent Development

11.30 MtoZ-Biolabs

11.30.1 MtoZ-Biolabs Company Details

11.30.2 MtoZ-Biolabs Business Overview

11.30.3 MtoZ-Biolabs Proteomics Research Services Introduction

11.30.4 MtoZ-Biolabs Revenue in Proteomics Research Services Business (2021–2026)

11.30.5 MtoZ-Biolabs Recent Development

11.31 Shanghai Majorbio Bio-Pharm

11.31.1 Shanghai Majorbio Bio-Pharm Company Details

11.31.2 Shanghai Majorbio Bio-Pharm Business Overview

11.31.3 Shanghai Majorbio Bio-Pharm Proteomics Research Services Introduction

11.31.4 Shanghai Majorbio Bio-Pharm Revenue in Proteomics Research Services Business (2021–2026)

11.31.5 Shanghai Majorbio Bio-Pharm Recent Development

11.32 Firalis Molecular Precision

11.32.1 Firalis Molecular Precision Company Details

11.32.2 Firalis Molecular Precision Business Overview

11.32.3 Firalis Molecular Precision Proteomics Research Services Introduction

11.32.4 Firalis Molecular Precision Revenue in Proteomics Research Services Business (2021–2026)

11.32.5 Firalis Molecular Precision Recent Development

11.33 CD Genomics

11.33.1 CD Genomics Company Details

11.33.2 CD Genomics Business Overview

11.33.3 CD Genomics Proteomics Research Services Introduction

11.33.4 CD Genomics Revenue in Proteomics Research Services Business (2021–2026)

11.33.5 CD Genomics Recent Development

11.34 MRM Proteomics

11.34.1 MRM Proteomics Company Details

11.34.2 MRM Proteomics Business Overview

11.34.3 MRM Proteomics Proteomics Research Services Introduction

11.34.4 MRM Proteomics Revenue in Proteomics Research Services Business (2021–2026)

11.34.5 MRM Proteomics Recent Development

11.35 Panome Bio

11.35.1 Panome Bio Company Details

11.35.2 Panome Bio Business Overview

11.35.3 Panome Bio Proteomics Research Services Introduction

11.35.4 Panome Bio Revenue in Proteomics Research Services Business (2021–2026)

11.35.5 Panome Bio Recent Development

11.36 Beijing Biomarker Technologies

11.36.1 Beijing Biomarker Technologies Company Details

11.36.2 Beijing Biomarker Technologies Business Overview

11.36.3 Beijing Biomarker Technologies Proteomics Research Services Introduction

11.36.4 Beijing Biomarker Technologies Revenue in Proteomics Research Services Business (2021–2026)

11.36.5 Beijing Biomarker Technologies Recent Development

11.37 Sampled (Infinity Biologix)

11.37.1 Sampled (Infinity Biologix) Company Details

11.37.2 Sampled (Infinity Biologix) Business Overview

11.37.3 Sampled (Infinity Biologix) Proteomics Research Services Introduction

11.37.4 Sampled (Infinity Biologix) Revenue in Proteomics Research Services Business (2021–2026)

11.37.5 Sampled (Infinity Biologix) Recent Development

11.38 Sinotech Genomics

11.38.1 Sinotech Genomics Company Details

11.38.2 Sinotech Genomics Business Overview

11.38.3 Sinotech Genomics Proteomics Research Services Introduction

11.38.4 Sinotech Genomics Revenue in Proteomics Research Services Business (2021–2026)

11.38.5 Sinotech Genomics Recent Development

11.39 Applied Biomics

11.39.1 Applied Biomics Company Details

11.39.2 Applied Biomics Business Overview

11.39.3 Applied Biomics Proteomics Research Services Introduction

11.39.4 Applied Biomics Revenue in Proteomics Research Services Business (2021–2026)

11.39.5 Applied Biomics Recent Development

11.40 Westlake Omics

11.40.1 Westlake Omics Company Details

11.40.2 Westlake Omics Business Overview

11.40.3 Westlake Omics Proteomics Research Services Introduction

11.40.4 Westlake Omics Revenue in Proteomics Research Services Business (2021–2026)

11.40.5 Westlake Omics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Proteomics Research Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Standard Proteomics

Table 3. Key Players of Modified Proteomics

Table 4. Key Players of Spatial Proteomics

Table 5. Key Players of Blood Proteomics

Table 6. Key Players of Other Proteomics

Table 7. Global Proteomics Research Services Market Size Growth Rate by End User (US$ Million): 2021 vs 2025 vs 2032

Table 8. Key Players of Universities and Research Institutes

Table 9. Key Players of Hospitals

Table 10. Key Players of Pharmaceutical Companies

Table 11. Key Players of Others

Table 12. Global Proteomics Research Services Market Size Growth Rate by Research Areas (US$ Million): 2021 vs 2025 vs 2032

Table 13. Key Players of Oncology

Table 14. Key Players of Cardiovascular

Table 15. Key Players of Agriculture

Table 16. Key Players of Neuroscience

Table 17. Key Players of Other

Table 18. Global Proteomics Research Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Proteomics Research Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global Proteomics Research Services Market Size by Region (US$ Million), 2021–2026

Table 21. Global Proteomics Research Services Market Share by Region (2021–2026)

Table 22. Global Proteomics Research Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 23. Global Proteomics Research Services Market Share by Region (2027–2032)

Table 24. Proteomics Research Services Market Trends

Table 25. Proteomics Research Services Market Drivers

Table 26. Proteomics Research Services Market Challenges

Table 27. Proteomics Research Services Market Restraints

Table 28. Global Proteomics Research Services Revenue by Players (US$ Million), 2021–2026

Table 29. Global Proteomics Research Services Market Share by Players (2021–2026)

Table 30. Global Top Proteomics Research Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Proteomics Research Services Revenue, 2025

Table 31. Ranking of Global Top Proteomics Research Services Companies by Revenue (US$ Million) in 2025

Table 32. Global 5 Largest Players Market Share by Proteomics Research Services Revenue (CR5 and HHI), 2021–2026

Table 33. Global Key Players of Proteomics Research Services, Headquarters and Area Served

Table 34. Global Key Players of Proteomics Research Services, Products and Applications

Table 35. Global Key Players of Proteomics Research Services, Date of General Availability (GA)

Table 36. Mergers and Acquisitions, Expansion Plans

Table 37. Global Proteomics Research Services Market Size by Type (US$ Million), 2021–2026

Table 38. Global Proteomics Research Services Revenue Market Share by Type (2021–2026)

Table 39. Global Proteomics Research Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 40. Global Proteomics Research Services Revenue Market Share by Type (2027–2032)

Table 41. Global Proteomics Research Services Market Size by Application (US$ Million), 2021–2026

Table 42. Global Proteomics Research Services Revenue Market Share by Application (2021–2026)

Table 43. Global Proteomics Research Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 44. Global Proteomics Research Services Revenue Market Share by Application (2027–2032)

Table 45. North America Proteomics Research Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. North America Proteomics Research Services Market Size by Country (US$ Million), 2021–2026

Table 47. North America Proteomics Research Services Market Size by Country (US$ Million), 2027–2032

Table 48. Europe Proteomics Research Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Europe Proteomics Research Services Market Size by Country (US$ Million), 2021–2026

Table 50. Europe Proteomics Research Services Market Size by Country (US$ Million), 2027–2032

Table 51. Asia-Pacific Proteomics Research Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 52. Asia-Pacific Proteomics Research Services Market Size by Region (US$ Million), 2021–2026

Table 53. Asia-Pacific Proteomics Research Services Market Size by Region (US$ Million), 2027–2032

Table 54. Latin America Proteomics Research Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Latin America Proteomics Research Services Market Size by Country (US$ Million), 2021–2026

Table 56. Latin America Proteomics Research Services Market Size by Country (US$ Million), 2027–2032

Table 57. Middle East & Africa Proteomics Research Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 58. Middle East & Africa Proteomics Research Services Market Size by Country (US$ Million), 2021–2026

Table 59. Middle East & Africa Proteomics Research Services Market Size by Country (US$ Million), 2027–2032

Table 60. Olink (Thermo Fisher Scientific) Company Details

Table 61. Olink (Thermo Fisher Scientific) Business Overview

Table 62. Olink (Thermo Fisher Scientific) Proteomics Research Services Product

Table 63. Olink (Thermo Fisher Scientific) Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 64. Olink (Thermo Fisher Scientific) Recent Development

Table 65. SomaLogic (Illumina) Company Details

Table 66. SomaLogic (Illumina) Business Overview

Table 67. SomaLogic (Illumina) Proteomics Research Services Product

Table 68. SomaLogic (Illumina) Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 69. SomaLogic (Illumina) Recent Development

Table 70. CellCarta Company Details

Table 71. CellCarta Business Overview

Table 72. CellCarta Proteomics Research Services Product

Table 73. CellCarta Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 74. CellCarta Recent Development

Table 75. PTM BIO Company Details

Table 76. PTM BIO Business Overview

Table 77. PTM BIO Proteomics Research Services Product

Table 78. PTM BIO Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 79. PTM BIO Recent Development

Table 80. Standard Biotools Company Details

Table 81. Standard Biotools Business Overview

Table 82. Standard Biotools Proteomics Research Services Product

Table 83. Standard Biotools Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 84. Standard Biotools Recent Development

Table 85. Labcorp Company Details

Table 86. Labcorp Business Overview

Table 87. Labcorp Proteomics Research Services Product

Table 88. Labcorp Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 89. Labcorp Recent Development

Table 90. BostonGene Company Details

Table 91. BostonGene Business Overview

Table 92. BostonGene Proteomics Research Services Product

Table 93. BostonGene Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 94. BostonGene Recent Development

Table 95. APTBIO Company Details

Table 96. APTBIO Business Overview

Table 97. APTBIO Proteomics Research Services Product

Table 98. APTBIO Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 99. APTBIO Recent Development

Table 100. Cell Signaling Technology (CST) Company Details

Table 101. Cell Signaling Technology (CST) Business Overview

Table 102. Cell Signaling Technology (CST) Proteomics Research Services Product

Table 103. Cell Signaling Technology (CST) Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 104. Cell Signaling Technology (CST) Recent Development

Table 105. Inotiv Company Details

Table 106. Inotiv Business Overview

Table 107. Inotiv Proteomics Research Services Product

Table 108. Inotiv Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 109. Inotiv Recent Development

Table 110. Bruker Spatial Biology Company Details

Table 111. Bruker Spatial Biology Business Overview

Table 112. Bruker Spatial Biology Proteomics Research Services Product

Table 113. Bruker Spatial Biology Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 114. Bruker Spatial Biology Recent Development

Table 115. BGI Genomics Company Details

Table 116. BGI Genomics Business Overview

Table 117. BGI Genomics Proteomics Research Services Product

Table 118. BGI Genomics Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 119. BGI Genomics Recent Development

Table 120. Biognosys Company Details

Table 121. Biognosys Business Overview

Table 122. Biognosys Proteomics Research Services Product

Table 123. Biognosys Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 124. Biognosys Recent Development

Table 125. Crown Bioscience Company Details

Table 126. Crown Bioscience Business Overview

Table 127. Crown Bioscience Proteomics Research Services Product

Table 128. Crown Bioscience Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 129. Crown Bioscience Recent Development

Table 130. Eurofins Scientific Company Details

Table 131. Eurofins Scientific Business Overview

Table 132. Eurofins Scientific Proteomics Research Services Product

Table 133. Eurofins Scientific Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 134. Eurofins Scientific Recent Development

Table 135. Charles River Laboratories Company Details

Table 136. Charles River Laboratories Business Overview

Table 137. Charles River Laboratories Proteomics Research Services Product

Table 138. Charles River Laboratories Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 139. Charles River Laboratories Recent Development

Table 140. Discovery Life Sciences Company Details

Table 141. Discovery Life Sciences Business Overview

Table 142. Discovery Life Sciences Proteomics Research Services Product

Table 143. Discovery Life Sciences Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 144. Discovery Life Sciences Recent Development

Table 145. Shanghai OE Biotech Company Details

Table 146. Shanghai OE Biotech Business Overview

Table 147. Shanghai OE Biotech Proteomics Research Services Product

Table 148. Shanghai OE Biotech Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 149. Shanghai OE Biotech Recent Development

Table 150. Biodesix Company Details

Table 151. Biodesix Business Overview

Table 152. Biodesix Proteomics Research Services Product

Table 153. Biodesix Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 154. Biodesix Recent Development

Table 155. Novogene Company Details

Table 156. Novogene Business Overview

Table 157. Novogene Proteomics Research Services Product

Table 158. Novogene Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 159. Novogene Recent Development

Table 160. OmicScouts (Momentum Biotechnologies) Company Details

Table 161. OmicScouts (Momentum Biotechnologies) Business Overview

Table 162. OmicScouts (Momentum Biotechnologies) Proteomics Research Services Product

Table 163. OmicScouts (Momentum Biotechnologies) Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 164. OmicScouts (Momentum Biotechnologies) Recent Development

Table 165. Lc-Bio Technologies Company Details

Table 166. Lc-Bio Technologies Business Overview

Table 167. Lc-Bio Technologies Proteomics Research Services Product

Table 168. Lc-Bio Technologies Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 169. Lc-Bio Technologies Recent Development

Table 170. Creative Proteomics Company Details

Table 171. Creative Proteomics Business Overview

Table 172. Creative Proteomics Proteomics Research Services Product

Table 173. Creative Proteomics Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 174. Creative Proteomics Recent Development

Table 175. Metware Biotechnology Company Details

Table 176. Metware Biotechnology Business Overview

Table 177. Metware Biotechnology Proteomics Research Services Product

Table 178. Metware Biotechnology Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 179. Metware Biotechnology Recent Development

Table 180. GENEWIZ (Azenta Life Sciences) Company Details

Table 181. GENEWIZ (Azenta Life Sciences) Business Overview

Table 182. GENEWIZ (Azenta Life Sciences) Proteomics Research Services Product

Table 183. GENEWIZ (Azenta Life Sciences) Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 184. GENEWIZ (Azenta Life Sciences) Recent Development

Table 185. CDI Labs Company Details

Table 186. CDI Labs Business Overview

Table 187. CDI Labs Proteomics Research Services Product

Table 188. CDI Labs Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 189. CDI Labs Recent Development

Table 190. Evotec Company Details

Table 191. Evotec Business Overview

Table 192. Evotec Proteomics Research Services Product

Table 193. Evotec Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 194. Evotec Recent Development

Table 195. MS Bioworks Company Details

Table 196. MS Bioworks Business Overview

Table 197. MS Bioworks Proteomics Research Services Product

Table 198. MS Bioworks Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 199. MS Bioworks Recent Development

Table 200. Shanghai Bioprofile Company Details

Table 201. Shanghai Bioprofile Business Overview

Table 202. Shanghai Bioprofile Proteomics Research Services Product

Table 203. Shanghai Bioprofile Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 204. Shanghai Bioprofile Recent Development

Table 205. MtoZ-Biolabs Company Details

Table 206. MtoZ-Biolabs Business Overview

Table 207. MtoZ-Biolabs Proteomics Research Services Product

Table 208. MtoZ-Biolabs Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 209. MtoZ-Biolabs Recent Development

Table 210. Shanghai Majorbio Bio-Pharm Company Details

Table 211. Shanghai Majorbio Bio-Pharm Business Overview

Table 212. Shanghai Majorbio Bio-Pharm Proteomics Research Services Product

Table 213. Shanghai Majorbio Bio-Pharm Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 214. Shanghai Majorbio Bio-Pharm Recent Development

Table 215. Firalis Molecular Precision Company Details

Table 216. Firalis Molecular Precision Business Overview

Table 217. Firalis Molecular Precision Proteomics Research Services Product

Table 218. Firalis Molecular Precision Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 219. Firalis Molecular Precision Recent Development

Table 220. CD Genomics Company Details

Table 221. CD Genomics Business Overview

Table 222. CD Genomics Proteomics Research Services Product

Table 223. CD Genomics Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 224. CD Genomics Recent Development

Table 225. MRM Proteomics Company Details

Table 226. MRM Proteomics Business Overview

Table 227. MRM Proteomics Proteomics Research Services Product

Table 228. MRM Proteomics Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 229. MRM Proteomics Recent Development

Table 230. Panome Bio Company Details

Table 231. Panome Bio Business Overview

Table 232. Panome Bio Proteomics Research Services Product

Table 233. Panome Bio Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 234. Panome Bio Recent Development

Table 235. Beijing Biomarker Technologies Company Details

Table 236. Beijing Biomarker Technologies Business Overview

Table 237. Beijing Biomarker Technologies Proteomics Research Services Product

Table 238. Beijing Biomarker Technologies Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 239. Beijing Biomarker Technologies Recent Development

Table 240. Sampled (Infinity Biologix) Company Details

Table 241. Sampled (Infinity Biologix) Business Overview

Table 242. Sampled (Infinity Biologix) Proteomics Research Services Product

Table 243. Sampled (Infinity Biologix) Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 244. Sampled (Infinity Biologix) Recent Development

Table 245. Sinotech Genomics Company Details

Table 246. Sinotech Genomics Business Overview

Table 247. Sinotech Genomics Proteomics Research Services Product

Table 248. Sinotech Genomics Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 249. Sinotech Genomics Recent Development

Table 250. Applied Biomics Company Details

Table 251. Applied Biomics Business Overview

Table 252. Applied Biomics Proteomics Research Services Product

Table 253. Applied Biomics Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 254. Applied Biomics Recent Development

Table 255. Westlake Omics Company Details

Table 256. Westlake Omics Business Overview

Table 257. Westlake Omics Proteomics Research Services Product

Table 258. Westlake Omics Revenue in Proteomics Research Services Business (US$ Million), 2021–2026

Table 259. Westlake Omics Recent Development

Table 260. Research Programs/Design for This Report

Table 261. Key Data Information from Secondary Sources

Table 262. Key Data Information from Primary Sources

Table 263. Authors List of This Report

List of Figures

Figure 1. Proteomics Research Services Picture

Figure 2. Global Proteomics Research Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Proteomics Research Services Market Share by Type: 2025 vs 2032

Figure 4. Standard Proteomics Features

Figure 5. Modified Proteomics Features

Figure 6. Spatial Proteomics Features

Figure 7. Blood Proteomics Features

Figure 8. Other Proteomics Features

Figure 9. Global Proteomics Research Services Market Size Comparison by End User (US$ Million), 2021–2032

Figure 10. Universities and Research Institutes Features

Figure 11. Hospitals Features

Figure 12. Pharmaceutical Companies Features

Figure 13. Others Features

Figure 14. Global Proteomics Research Services Market Size Comparison by Research Areas (US$ Million), 2021–2032

Figure 15. Oncology Features

Figure 16. Cardiovascular Features

Figure 17. Agriculture Features

Figure 18. Neuroscience Features

Figure 19. Other Features

Figure 20. Global Proteomics Research Services Market Size by Application (US$ Million), 2021–2032

Figure 21. Global Proteomics Research Services Market Share by Application: 2025 vs 2032

Figure 22. Clinical Diagnostics Case Studies

Figure 23. Drug Discovery Case Studies

Figure 24. Others Case Studies

Figure 25. Proteomics Research Services Report Years Considered

Figure 26. Global Proteomics Research Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 27. Global Proteomics Research Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 28. Global Proteomics Research Services Market Share by Region: 2025 vs 2032

Figure 29. Global Proteomics Research Services Market Share by Players in 2025

Figure 30. Global Proteomics Research Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 31. The Top 10 and 5 Players Market Share by Proteomics Research Services Revenue in 2025

Figure 32. North America Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. North America Proteomics Research Services Market Share by Country (2021–2032)

Figure 34. United States Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Canada Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Europe Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Europe Proteomics Research Services Market Share by Country (2021–2032)

Figure 38. Germany Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. France Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. U.K. Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Italy Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Russia Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Ireland Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Asia-Pacific Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Asia-Pacific Proteomics Research Services Market Share by Region (2021–2032)

Figure 46. China Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Japan Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. South Korea Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Southeast Asia Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. India Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Australia & New Zealand Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Latin America Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Latin America Proteomics Research Services Market Share by Country (2021–2032)

Figure 54. Mexico Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Brazil Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Middle East & Africa Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Middle East & Africa Proteomics Research Services Market Share by Country (2021–2032)

Figure 58. Israel Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. Saudi Arabia Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 60. UAE Proteomics Research Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 61. Olink (Thermo Fisher Scientific) Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 62. SomaLogic (Illumina) Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 63. CellCarta Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 64. PTM BIO Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 65. Standard Biotools Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 66. Labcorp Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 67. BostonGene Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 68. APTBIO Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 69. Cell Signaling Technology (CST) Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 70. Inotiv Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 71. Bruker Spatial Biology Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 72. BGI Genomics Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 73. Biognosys Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 74. Crown Bioscience Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 75. Eurofins Scientific Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 76. Charles River Laboratories Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 77. Discovery Life Sciences Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 78. Shanghai OE Biotech Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 79. Biodesix Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 80. Novogene Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 81. OmicScouts (Momentum Biotechnologies) Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 82. Lc-Bio Technologies Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 83. Creative Proteomics Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 84. Metware Biotechnology Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 85. GENEWIZ (Azenta Life Sciences) Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 86. CDI Labs Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 87. Evotec Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 88. MS Bioworks Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 89. Shanghai Bioprofile Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 90. MtoZ-Biolabs Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 91. Shanghai Majorbio Bio-Pharm Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 92. Firalis Molecular Precision Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 93. CD Genomics Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 94. MRM Proteomics Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 95. Panome Bio Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 96. Beijing Biomarker Technologies Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 97. Sampled (Infinity Biologix) Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 98. Sinotech Genomics Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 99. Applied Biomics Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 100. Westlake Omics Revenue Growth Rate in Proteomics Research Services Business (2021–2026)

Figure 101. Bottom-up and Top-down Approaches for This Report

Figure 102. Data Triangulation

Figure 103. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Proteomics Research Services market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Proteomics Research Services market is 10.4% 2026 to 2032.

Which region is expected to have the highest market share? shouQi

What was the global market size of Proteomics Research Services in 2032? shouQi

What was the global market size of Proteomics Research Services in 2026? shouQi

Which companies rank high in the global Proteomics Research Services market? shouQi

Related Reports

Global Proteomics Research Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Proteomics Research Services market is projected to grow from US$ 3392 million in 2025 to US$ 6602 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-16
Pages: 217
USD 4900.00
(Single User License)
Global Proteomics Research Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Proteomics Research Services market size was US$ 3392 million in 2025 and is forecast to reach a readjusted size of US$ 6602 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published Date: 2026-07-16
Pages: 200
USD 4250.00
(Single User License)
Proteomics Research Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Proteomics Research Services was estimated to be worth US$ 3392 million in 2025 and is projected to reach US$ 6602 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-07-16
Pages: 195
USD 3950.00
(Single User License)

Global Proteomics Research Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Proteomics Research Services market is projected to grow from US$ 3392 million in 2025 to US$ 6602 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-16
Pages: 217
USD 4900.00 (Single User License)
Global Proteomics Research Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Proteomics Research Services market size was US$ 3392 million in 2025 and is forecast to reach a readjusted size of US$ 6602 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published: 2026-07-16
Pages: 200
USD 4250.00 (Single User License)
Proteomics Research Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Proteomics Research Services was estimated to be worth US$ 3392 million in 2025 and is projected to reach US$ 6602 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-07-16
Pages: 195
USD 3950.00 (Single User License)